Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.5% 16.875 16.25 17.50 16.875 16.625 16.63 274,064 14:00:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.4 -0.9 - 26

Skinbiotherapeutics Share Discussion Threads

Showing 7601 to 7623 of 8050 messages
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
DateSubjectAuthorDiscuss
12/9/2020
13:49
Well if those comments are aimed at me I announced my sale at the time and said I would probably come back in if the price went down. Because of that I thought I ought to mention the repurchase. Also we do not know this is the new low.
nik7907
12/9/2020
13:46
Shrewd, Where is the info about sederma being 12 months ahead of schedule coming from?
slartybartfaster
12/9/2020
13:27
Slarty Most of its rubbish anyway. Plenty to come here. Nice addition this week, sederma have replicated the results of skinbiotix and psoriasis upto 12 months ahead of schedule. S
shrewdmole
11/9/2020
18:50
BBs are full of traders exiting at the peak and buying again at the new low. Bigger egos than shares.
slartybartfaster
11/9/2020
09:51
It has proved a wise move Nik! Looks like cracking 30p is going to be a challenge, but as many keep saying, nothing has changed here and hopefully we will breach new highs before too long.
lovewinshatelosses
11/9/2020
09:16
I mentioned a while ago I top sliced here at 25p. Decided to put the proceeds back in again, so I suppose it is now a trade?
nik7907
10/9/2020
22:48
Let’s hope they don’t try and repeat it..could be a severe reversal. Opti could be hovering too, looks to be cash light?
rayrac
10/9/2020
13:30
Look at the lows around 6p. It was accompanied by a spike in volume, so its not impossible that someone is banking circa 230/ 240% gains in 6 months. That's some return!!
pj 1
10/9/2020
12:48
Who is selling here now? This is most annoying. Going to buy some more when we revisit 15p, which seems likely now. AIM is like a round of golf sometimes!
lovewinshatelosses
10/9/2020
12:44
Picked these up on my spread, from 7p still healthy
anderson3
10/9/2020
12:19
I notice you haven’t slartyfartfaster!
rayrac
10/9/2020
12:01
Last count, there were 6 companies interested in our tech
anderson3
10/9/2020
11:37
Interesting comment re the sub-contracting rayrac. Didn't know that Croda were a registered charity, after all, how many companies do you know outlay £5m of their own money upfront out of the goodness of their hearts?
aquaesulis01
10/9/2020
11:12
Just to echo some comments above. Great new appt, company progressing well with excellent partners. Commercialisation won't happen overnight. Also, unfortunately (or not), opportunity to try and trade for those braver than me.
m4rtinu
10/9/2020
11:09
Elric has done a number of detailed Interviews investors can make their own Mind up
atlantic57
10/9/2020
10:59
Trouble is, nothing is fundermentally any good without some verification on the effective front. And I get a feeling, that Croda are setting up a production line just for sbtx...maybe because they have been asked, as sbtx doesn’t have that ability? Ie, sub-contracting. Don’t listen to elrico, he’s inclined to bs on behalf of his contacts?
rayrac
10/9/2020
10:39
Agreed and I am holding quite a few shares here already. Not selling any either.
rafboy
10/9/2020
10:25
No rhyme or reason to it either. Nothing has fundamentally changed to my knowledge. In fact at these levels it is worth a top up as when that trial kicks off in Q1 next year this stock will be hard to get as it always is when on the rise.
madaboutmed
10/9/2020
10:17
Blimey heading south again. Be nice to stay above 20p at the very least but not today it seems.
rafboy
10/9/2020
08:16
From a business point of view, this makes perfect sense because it not only allows the form CEO. Cath O'Neil more time in the labs, along with other lab geeks exorcising their creative genius for the future. SkinBiotherapeutics CEO. Stuart Ashman commented to me: "Jonathan brings a much needed clinical experience to advance our MediBiotix. Jonathan also adds a wealth of connections in the clinical research field that will assist us with the various clinical trial we need to execute over the next few years." https://lemminginvestors.blogspot.com/2020/09/skinbiotherapeutics-adds-senior-medial.html?m=1
elrico
09/9/2020
14:15
rayrac et al, probably worth listening to the Shareprophets presemtation on the Skinbio website again. There it is made clear that the Croda deal, where the spend by Croda on the £5m dedicated skin biotix production line, which cannot be used for any other product, was viewed by Skinbio as the equivalent to receiving an upfront milestone payment. Why? Because the deal included the option for Skinbio to buy back the end product at near cost price and sell it direct if they so desire. In practice, the royalties of a successful anti ageing product are likely to be in the realm of £250M using matrixyl as a guideline with the additional spinoff that it will accelerate the route to market for Pharma Biotix. In terms of will it work; well don't forget that the reason for Croda interest was that the impact on the elastic fibres in the skin was found by accident when analysing the safety data tests; so I would suggest it is is very unlikely that it will disappoint.
aquaesulis01
09/9/2020
11:05
I do my best.😇
rayrac
09/9/2020
10:50
RayracI am obviously aware of your history with opti and here. To be honest you have been filtered for years but for some reason I decided to look at your post here and respond. It's obvious we will never agree so I will discontinue this nowI am not sure that croda investing 5m to get to production is giving it to them on a plate. Double digit royalties will follow and I am happy for that to follow. Although it's quite clear from your post that Stuart should have got you to do the negotiating with croda as you obviously you would have negotiated much better terms so maybe you can suggest that to him for the next deal. I realise that you are only here out of the goodness of your heart to save investors their wealth and I think that is jolly noble of you. There is only another few hundred companies on Aim for you to provide the same service
gary hindsight
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201202 23:06:41